+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alkermes plc - logo

Alkermes is a leader in innovative medicines that address the needs of people living with debilitating diseases. Alkermes develops products that are designed to make a meaningful difference in the way patients manage their disease. Alkermes produces innovative treatments for major clinical conditions specifically focused on central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis.

From
From
Global Schizophrenia Drugs Market 2021-2025 - Product Thumbnail Image

Global Schizophrenia Drugs Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
  • Global
From
Substance Abuse Treatment - Global Strategic Business Report - Product Thumbnail Image

Substance Abuse Treatment - Global Strategic Business Report

  • Report
  • April 2024
  • 197 Pages
  • Global
From
Addiction Treatment: Global Strategic Business Report - Product Thumbnail Image

Addiction Treatment: Global Strategic Business Report

  • Report
  • April 2024
  • 242 Pages
  • Global
From
Opium (Opioid) Addiction Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Opium (Opioid) Addiction Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • February 2020
  • 437 Pages
  • Global
From
From
Global Addictions Therapeutics Market 2023-2027 - Product Thumbnail Image

Global Addictions Therapeutics Market 2023-2027

  • Report
  • October 2022
  • 120 Pages
  • Global
From
Loading Indicator